Oncology
Sarah Goldberg, M.D., M.P.H.
Associate Professor of Medicine (Medical Oncology & Hematology); Chief, Thoracic Oncology; Co-Director, Center for Thoracic Cancers; Associate Program Director, Medical Oncology-Hematology Fellowship Program
Dr. Sarah Goldberg is a thoracic oncologist at Yale Cancer Center specializing in cancers of the chest, with primary focus on lung cancer, mesothelioma, and thymoma. As Chief of Thoracic Oncology and Associate Professor of Medicine in Medical Oncology at Yale School of Medicine, she provides clinical care while conducting extensive clinical and translational research. Her research centers on biomarkers and novel treatment strategies in non-small cell lung cancer, with specific interests in EGFR
20+
Years in Practice
Credentials
Education & Training
- Harvard School of Public Health — Master of Public Health (MPH)
- Mount Sinai School of Medicine — M.D. (2006)
- Massachusetts General Hospital — Residency (2009)
- Dana-Farber Cancer Institute — Fellowship (2012)
Peer Recognition
- Lung Cancer Research Foundation (LCRF) | Bayer Pharmaceuticals — LCRF | Bayer Lung Cancer Research Award
2025
- Yale Cancer Center — Award for Teaching Excellence
2023
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Yale Cancer Center
- Smilow Cancer Hospital at Yale New Haven
Languages
English
Experience
20+ years in practice